Other
Maintenance Treatment
0
Pipeline Programs↗
10
Active Trials↗
9
Companies Involved↗
Maintenance Treatment is an early-stage landscape with 0 programs across 9 companies. The most active players are Roche, Laboratoire français de Fractionnement et de Biotechnologies, AGC Biologics S.p.A..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
56
clinical trials
Unknown status19 · 34%
Completed18 · 32%
Recruiting8 · 14%
Terminated6 · 11%
Withdrawn3 · 5%
Active, not recruiting2 · 4%
Clinical Trials
Trial Activity
56 trials
Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer
Recruiting·AAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia·Phase 2·NCT07085572·31 enrolled
Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC
Recruiting·—·Phase 2·NCT07110103·20 enrolled
A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.
Recruiting·TThe First Affiliated Hospital with Nanjing Medical University·N/A·NCT05967949·200 enrolled
Maintenance Treatment of Bipolar Depression
Completed·TThe University of Texas Health Science Center at San Antonio·Phase 4·NCT00183469·86 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)